Why is Hemo Organic falling/rising?

As of 10-Jul, Hemo Organic Ltd's stock price is currently at 9.54, reflecting a decrease of 0.46, or 4.6%. The stock has underperformed its sector by 5.55% today and has experienced a trend reversal, falling after two consecutive days of gains. It is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has declined by 6.10%, and its year-to-date performance shows a significant drop of 23.43%. Despite some positive quarterly results, including the highest PBDIT and PAT figures, the company faces challenges such as a negative book value, high debt levels, and a weak long-term growth outlook, which contribute to its recent price decline.
In the broader market context, Hemo Organic's performance has been notably poor compared to the benchmark, with a 1-year return of -15.35% against the Sensex's gain of 4.09%. This consistent underperformance over the past three years, coupled with a negative EBITDA and a high debt-to-equity ratio, raises concerns among investors. The stock's liquidity appears adequate, with a significant rise in delivery volume, but the overall sentiment remains negative due to the company's weak fundamentals and ongoing financial struggles.